BLAIR WILLIAM & CO/IL - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$292,485
-22.5%
9,2500.0%0.00%0.0%
Q2 2023$377,215
+39.6%
9,250
+27.6%
0.00%0.0%
Q1 2023$270,208
+5.2%
7,250
-1.5%
0.00%0.0%
Q4 2022$256,790
-56.5%
7,360
-30.2%
0.00%
-66.7%
Q3 2022$590,000
+10.1%
10,538
+1.7%
0.00%
+50.0%
Q2 2022$536,000
-28.8%
10,360
-0.0%
0.00%
-33.3%
Q1 2022$753,000
-31.2%
10,362
+11.9%
0.00%0.0%
Q4 2021$1,095,000
-10.4%
9,262
+1.7%
0.00%
-25.0%
Q3 2021$1,222,000
-17.2%
9,1100.0%0.00%
-20.0%
Q2 2021$1,475,000
+101.8%
9,1100.0%0.01%
+66.7%
Q1 2021$731,000
+65.8%
9,110
+12.3%
0.00%
+50.0%
Q4 2020$441,000
+67.7%
8,110
-58.9%
0.00%0.0%
Q3 2019$263,000
-18.6%
19,7300.0%0.00%0.0%
Q2 2019$323,000
-15.0%
19,730
-11.4%
0.00%0.0%
Q1 2019$380,000
+26.2%
22,260
+0.9%
0.00%0.0%
Q4 2018$301,000
+5.2%
22,060
+120.6%
0.00%0.0%
Q3 2018$286,000
-34.7%
10,000
-37.5%
0.00%
-33.3%
Q2 2018$438,00016,0000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders